Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

19.26
Delayed Data
As of 4:00pm ET
 +0.66 / +3.55%
Today’s Change
12.05
Today|||52-Week Range
21.75
+4.56%
Year-to-Date
No recent news for Amphastar Pharmaceuticals Inc.

Today’s Trading

Previous close18.60
Today’s open18.64
Day’s range18.58 - 19.35
Volume262,921
Average volume (3 months)205,161
Market cap$855.2M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-35.92%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+1.45%
P/E ratioNM
Price/Sales3.43
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...-0.90-3.86%
RVNCRevance Therapeutics...-1.75-4.87%
VSARVersartis Inc-0.15-7.06%
HSKAHeska Corp+0.11+0.14%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$255.2M
Annual profit (last year)$10.5M
Net profit margin4.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
CEO, Director &
Chief Science Officer
Yong Feng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts